Financhill
Sell
23

CNVS Quote, Financials, Valuation and Earnings

Last price:
$2.07
Seasonality move :
14.13%
Day range:
$1.77 - $1.92
52-week range:
$1.77 - $7.39
Dividend yield:
0%
P/E ratio:
17.97x
P/S ratio:
0.42x
P/B ratio:
1.03x
Volume:
132.9K
Avg. volume:
113K
1-year change:
-60.97%
Market cap:
$35.4M
Revenue:
$78.2M
EPS (TTM):
-$0.09

Earnings Data

Next earnings date for CNVS
Feb 17
2026
Most recent earnings per share
-$0.31
Missed by $0.31
(Nov 14/2025)
Consensus Estimate
--
(Nov 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNVS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $21.6M -- -- -- --
02/17/2026 Q4 $20M -- -- -- --
11/14/2025 Q3 $12.7M $12.4M -$0.31 -- --
08/14/2025 Q2 $10.2M $11.1M -$0.21 -- --
06/27/2025 Q1 $14.3M $15.6M $0.04 -- --
02/13/2025 Q4 $36.4M $40.7M $0.40 -- --
11/14/2024 Q3 $10.7M $12.7M -$0.09 -- --
08/14/2024 Q2 $10.3M $9.1M -$0.20 -- --
03/31/2024 Q1 $10.6M $9.9M -$1.10 -- --
02/14/2024 Q4 $13.8M $13.3M -$0.22 -- --
09/30/2023 Q3 -- $13M -$0.04 -- --
06/30/2023 Q2 -- $13M -$0.37 -- --
03/31/2023 Q1 -- $12.5M -$0.35 -- --
02/14/2023 Q4 -- $27.9M $0.55 -- --
09/30/2022 Q3 -- $14M -$0.65 -- --
06/30/2022 Q2 -- $13.6M -$0.69 -- --
03/31/2022 Q1 -- $16.9M -$0.36 -- --
12/31/2021 Q4 -- $14.1M -$0.05 -- --
09/30/2021 Q3 -- $10.1M -$0.03 -- --
06/30/2021 Q2 -- $15M $0.60 -- --
03/31/2021 Q1 -- $8.3M -$0.83 -- --
12/31/2020 Q4 -- $10M -$1.42 -- --
09/30/2020 Q3 -- $7.2M -$4.65 -- --
06/30/2020 Q2 -- $6M -$4.22 -- --
03/31/2020 Q1 -- $7.7M -$1.67 -- --
12/31/2019 Q4 -- $11.5M -$1.06 -- --
09/30/2019 Q3 -- $10.2M -$1.54 -- --
06/30/2019 Q2 -- $9.8M -$2.67 -- --
03/31/2019 Q1 -- $12.1M -$3.54 -- --
12/31/2018 Q4 -- $14.6M -$1.76 -- --
09/30/2018 Q3 -- $13.7M -$1.89 -- --
06/30/2018 Q2 -- $13.1M -$1.80 -- --
03/31/2018 Q1 -- $17.7M -$0.02 -- --
12/31/2017 Q4 -- $18.5M -$4.00 -- --
09/30/2017 Q3 -- $16.3M -$12.00 -- --
06/30/2017 Q2 -- $15.2M -$9.60 -- --
03/31/2017 Q1 -- $19.6M -$16.44 -- --
12/31/2016 Q4 -- $24.4M -$1.40 -- --
09/30/2016 Q3 -- $23.9M -$1.60 -- --
06/30/2016 Q2 -- $22.5M -$14.00 -- --
03/31/2016 Q1 -- $23.2M -$19.06 -- --

Cineverse Corp. Earnings Questions

  • How Much did Cineverse Corp. Generate in Revenue Last Quarter?

    Cineverse Corp. reported $12.4M worth of top line sales in its most recent quarter.

  • Did Cineverse Corp. Beat Earnings Last Quarter?

    Cineverse Corp. announced earnings per share of -$0.31 which represents a miss of analyst forecast a -- per share.

  • Is Cineverse Corp. Profitable?

    Cineverse Corp. reported $6M that represents $0.33 per share over the last quarter.

  • What is the Analyst Consensus for Cineverse Corp. EPS Next Year?

    Cineverse Corp.'s earnings are forecast to grow from $0.18 per share to -- per share next year representing an increase of --.

  • When is Cineverse Corp.'s Earnings Date?

    Cineverse Corp.'s next earnings date is February 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
40
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
91
TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy
67
DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy
77
VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock